NorthWest Biotherapeutics Inc (NWBO)

[Doktornolittle]

"Celldex enrolled almost 750 GBM patients into the ACT-IV study in three years."

Screened patients were injected, and only enrolled if they showed a sufficient response to the treatment. So the number of patients that were screened was much larger than 750. Most were turned away. Those turned away were likely no longer elligible for other trials, in part because they had already been treated, and in part because it was too late.

Again, Celldex worded their statements about efficacy in a very clever manner, greatly exaggerating the true percentage of patients that were helped by the treatment. If they used the same deceptive language in presenting the option to patients, then they conned a large number of patients out of other therapy options, and you and Cramer helped them with that con by pumping Celldex continously, never mentioning this deceptive description of efficacy, and constantly hammering DCVax-L.